Home » Topics » Conferences

Conferences
RSS

Novel site of action for chimeric insulin-releasing peptide

June 12, 1997

BRL-48482 has potential for reducing cardiovascular risk in NIDDM

June 12, 1997

Phase III results for AY-4166

June 12, 1997

Pioglitazone improves insulin resistance in NIDDM

June 12, 1997

New preclinical studies on JTT-501

June 12, 1997

Clinical results in NIDDM reported for troglitazone

June 12, 1997

Efficacy of pioglitazone demonstrated in NIDDM patients

June 11, 1997

Midodrine efficacy in diabetic patients with orthostatic hypotension

June 11, 1997

Miglitol tested in specific population subgroups

June 11, 1997

Clinical results reported for Novo Nordisk insulinotropic agent

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.